"Meditab Holdings Ltd, Mauritius, a wholly owned subsidiary of the company, has entered into a definitive agreement to sell its entire 48.22 per cent equity interest in Jiangsu Cdymax Pharmaceuticals Co Ltd, China to an affiliate of one of the other shareholders of Jiangsu, for a total consideration of $18.5 million," Cipla said in a filing to the Bombay Stock Exchange.
The closing of the transaction is subject to receipt of applicable regulatory approvals in China, it added.
Representative image. Photograph: Reuters
Telangana allocates 11,000 acre land for mega pharma city
Ranbaxy brand may fade away as Sun takes charge
Investors' wealth crosses Rs 100 trillion
Sensex rises after a steep fall; Tata Steel, Hindalco up
Markets end flat; Mid-cap indices close at record closing highs